These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18627381)

  • 1. Cyclophosphamide-induced nail discoloration and skin hyperpigmentation: a rare presentation.
    Chittari K; Tagboto S; Tan BB
    Clin Exp Dermatol; 2009 Apr; 34(3):405-6. PubMed ID: 18627381
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanonychia following cyclophosphamide therapy.
    Gupta A; Kumar A; Suri D; Tiewsoh K
    Kidney Int; 2016 Dec; 90(6):1387. PubMed ID: 27884315
    [No Abstract]   [Full Text] [Related]  

  • 3. Peculiar pattern of nail pigmentation following cyclophosphamide therapy.
    Dave S; Thappa DM
    Dermatol Online J; 2003 Aug; 9(3):14. PubMed ID: 12952761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case 1. Diffuse melanonychia.
    White JM; Higgins EM
    Clin Exp Dermatol; 2004 May; 29(3):331-2. PubMed ID: 15115533
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanonychia--a perplexing differential diagnosis.
    Korzets Z; Rathaus M
    Isr Med Assoc J; 1999 Nov; 1(3):209. PubMed ID: 10731342
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependent melanonychia by mitoxantrone.
    Reinsberger C; Meuth SG; Wiendl H
    Mult Scler; 2009 Sep; 15(9):1131-2. PubMed ID: 19570819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal melanonychia and pseudo-Hutchinson sign associated with amlodipine.
    Sladden MJ; Mortimer NJ; Osborne JE
    Br J Dermatol; 2005 Jul; 153(1):219-20. PubMed ID: 16029363
    [No Abstract]   [Full Text] [Related]  

  • 9. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2010 Jun; 25(6):1760-6. PubMed ID: 20133280
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperpigmentation, nail dystrophy and alopecia with generalised intestinal polyposis: Cronkhite-Canada syndrome.
    Ho V; Banney L; Falhammar H
    Australas J Dermatol; 2008 Nov; 49(4):223-5. PubMed ID: 18855786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-related nail disease.
    Piraccini BM; Alessandrini A
    Clin Dermatol; 2013; 31(5):618-26. PubMed ID: 24079591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpigmented forearms and nail: a quiz.
    Kalabalikis D; Patsatsi A; Trakatelli MG; Pitsari P; Efstratiou I; Sotiriadis D
    Acta Derm Venereol; 2010 Nov; 90(6):657-9. PubMed ID: 21057763
    [No Abstract]   [Full Text] [Related]  

  • 13. Nail discoloration induced by doxycycline.
    Akcam M; Artan R; Akcam FZ; Yilmaz A
    Pediatr Infect Dis J; 2005 Sep; 24(9):845-6. PubMed ID: 16148859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide nail pigmentation.
    Adam BA
    Singapore Med J; 1981 Feb; 22(1):35-7. PubMed ID: 7017940
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxorubicin induced melanonychia.
    M I; Khairkar PH
    Indian Pediatr; 2003 Nov; 40(11):1094-5. PubMed ID: 14660845
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.
    Khan S; Bolton WK
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1001-4. PubMed ID: 24855281
    [No Abstract]   [Full Text] [Related]  

  • 17. Generalized skin hyperpigmentation and longitudinal melanonychia secondary to treatment with hydroxychloroquine in systemic lupus erythematosus.
    Sifuentes Giraldo WA; Grandal Platero M; de la Puente Bujidos C; Gámir Gámir ML
    Reumatol Clin; 2013; 9(6):381-2. PubMed ID: 23481508
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea.
    Hernández-Martín A; Ros-Forteza S; de Unamuno P
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera.
    Gropper CA; Don PC; Sadjadi MM
    Int J Dermatol; 1993 Oct; 32(10):731-3. PubMed ID: 8225715
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CON.
    van de Logt AE; Wetzels JF
    Kidney360; 2021 Nov; 2(11):1699-1701. PubMed ID: 35372989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.